Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||
| Net Income | -5,250 | -2,620 |
| Other Working Capital | -130 | 130 |
| Other Operating Activity | 860 | 1,980 |
| Operating Cash Flow | $-4,520 | $-510 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $0 | $0 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 5,820 | 700 |
| Financing Cash Flow | $5,820 | $700 |
| Exchange Rate Effect | -170 | 4 |
| Beginning Cash Position | 190 | 0 |
| End Cash Position | 1,310 | 190 |
| Net Cash Flow | $1,120 | $190 |
| Free Cash Flow | ||
| Operating Cash Flow | -4,520 | -510 |
| Free Cash Flow | -4,520 | -510 |